The Week in Review: Doing Deals

As the feeling of economic crisis recedes, other – more normal – stories are beginning to take the place of apocalyptic news. Last week in China life science, we saw an upsurge of interest in deal making. The ChinaBio® Partnering Forum was held in Shanghai, providing a venue for almost 600 meetings between young companies and global pharmas looking for promising technology. After a long dry spell, two China companies held IPOs, one listing in Shenzhen, the other in New York. And a $25 million venture capital infusion went to a China generic drug company. More details...